MedTrace Logo

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00003863 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 391

Last updated 2016-07-06

No results posted yet for this study

Summary

RATIONALE: Determination of genetic markers for aggressive non-Hodgkin's lymphoma may help identify patients with this disease and help predict the outcome of treatment.

PURPOSE: Diagnostic study to determine the genetic markers in patients who have aggressive non-Hodgkin's lymphoma.

Conditions

Interventions

GENETIC

comparative genomic hybridization

GENETIC

cytogenetic analysis

GENETIC

fluorescence in situ hybridization

GENETIC

gene rearrangement analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Raju Chaganti, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-06-30
Primary Completion
2005-05-31
Completion
2005-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003863 on ClinicalTrials.gov